Part 06 · Patient Communication
Two-Hat Provider Guide · Part 06 of 10
The patient-facing conversations in the two-hat model are where the model becomes real or where it falls apart. The legal framework, the credentialing, the operational separation — all of it is invisible to the veteran sitting in front of you. What they experience is the conversation. Getting it right matters as much as anything else in the model.
The first conversation: the federal-capacity disclosure
The most important conversation in a two-hat practice happens not in the cannabis evaluation visit, but in the federal-capacity visit when cannabis comes up — either because the veteran discloses use, or because the provider asks. The conversation needs to do three things at once: acknowledge the cannabis use without judgment, clarify what the provider can and cannot do in their federal capacity, and (where appropriate) explain that a separate path exists for cannabis evaluation if the veteran wants one.
The shape of this conversation, used by many two-hat providers:
- Acknowledgment. “Thank you for telling me. That information helps me take better care of you.” Veterans have often been managing disclosure anxiety for years; the simple act of receiving the disclosure without alarm matters.
- Clinical integration. “Let’s make sure we’re thinking about how cannabis interacts with the other things we’re managing.” The cannabis use becomes part of the clinical picture, the way any patient-reported behavior would.
- Boundary clarity. “In my VA Community Care capacity, I can’t recommend cannabis or help you access the state program. That’s federal rules, not my preference.” Most veterans understand this readily once it’s stated.
- The optional bridge. “I do happen to have a separate practice where I evaluate veterans for the state cannabis program, if that’s something you want to pursue. It’s entirely separate from your VA care, and there’s no pressure either way.” This part is offered, not pushed. Some veterans want it; some don’t.
The tone that distinguishes the conversation
The strongest two-hat providers describe the conversation as one of relief rather than promotion. The veteran has been carrying confusion or anxiety about their cannabis use. The conversation lets them put it down. Whether they choose to pursue cannabis evaluation through the state program is incidental; the value of the conversation is the clarity it provides regardless.
What veterans get wrong about VA cannabis policy
The most common veteran misunderstandings, in roughly descending order of frequency:
What to tell the veteran clearly
Many veterans approach the cannabis conversation expecting bad news. The reassurance worth delivering, in plain language: cannabis disclosure does not affect VA benefits. The Veterans Equal Access protections under VHA Directive 1315 are explicit. The veteran can be in a state medical cannabis program, can be receiving medical cannabis treatment from a state-licensed practitioner, and their VA care continues uninterrupted. The provider who delivers this reassurance honestly — without hedging, without warnings — gives the veteran something they may not have heard from anyone else in their care.
- “If I tell my VA doctor I use cannabis, I’ll lose my benefits.” Untrue. The Veterans Equal Access Act prohibits this. Disclosure carries no benefits consequence.
- “My VA doctor can write me a medical cannabis recommendation.” Untrue. VA providers operate under federal authority and cannot recommend cannabis in their VA capacity, regardless of state program availability.
- “If I’m in a state cannabis program, I can’t use VA care.” Untrue. State cannabis program participation does not affect VA care eligibility or benefits.
- “I can use cannabis at the VA medical center.” Untrue. Federal property prohibits cannabis possession or use, regardless of state law.
- “The VA will test me for cannabis.” Untrue in most contexts. Most VA clinical encounters do not involve cannabis testing, and a positive test does not affect benefits.
The two-hat provider, in their VA Community Care capacity, can address each of these directly. Correcting misconceptions is part of the federal-capacity care. It does not require crossing into recommendation.
What providers get wrong about the conversation
The most common provider missteps:
Mistake 1: Crossing into recommendation in the VA visit
A provider whose VA Community Care patient describes cannabis use and who responds with even soft recommendation language — “you might benefit from a higher dose” or “you should try a different strain” — has stepped out of their federal capacity into recommendation. Even if no formal recommendation is documented, the conversation has crossed the line the separation is supposed to maintain. The cleaner response: acknowledge, integrate clinically, refer to the separate evaluation practice if appropriate, but make no clinical recommendations about cannabis itself in the federal-capacity visit.
Mistake 2: Treating the state practice as a referral pipeline
Providers who use VA Community Care visits primarily as a recruiting channel for their separate cannabis evaluation practice undermine the model. The federal practice must serve federal patients, full stop. Mentioning the separate practice when it’s clinically relevant is appropriate; doing so as a routine practice promotion is not. The line between the two is sometimes subtle and worth examining honestly.
Mistake 3: Discussing the federal practice during the cannabis evaluation
The cannabis evaluation visit is its own clinical encounter. It is not a place to manage VA Community Care issues. Providers who blend the two — reviewing VA medications during the cannabis evaluation, adjusting VA-managed treatment plans during the cannabis visit — undermine the separation from the other direction. Each visit stays in its own lane.
The cannabis evaluation conversation itself
The cannabis evaluation visit, conducted under the state cannabis registration, follows the structure the state program requires. Most states have specific elements that must be documented: confirmation of the qualifying condition, review of the patient’s medical history relevant to cannabis suitability, discussion of risks and benefits, documentation of the recommendation (or non-recommendation).
The clinical content of the evaluation looks like any other focused medical evaluation. The provider takes a history relevant to cannabis suitability. Examines the patient where appropriate. Reviews documentation of the qualifying condition. Discusses what the evidence does and does not show about cannabis for the patient’s condition. Discusses likely benefits and risks. Documents the discussion and the recommendation outcome.
What distinguishes a strong cannabis evaluation from a weak one is honesty about evidence. Cannabis has meaningful evidence for some conditions (chronic pain syndromes, chemotherapy-induced nausea, certain seizure disorders). It has weaker evidence for many of the conditions for which it is requested. Providers who recommend cannabis indiscriminately serve their patients poorly. Providers who decline to recommend even when evidence supports it serve them equally poorly. The clinical judgment that matters here is the same clinical judgment that matters in any evaluation: what does the evidence say for this patient’s condition, and what would responsible care look like?
Documentation patterns
Each visit documents in the appropriate practice’s record. The federal-capacity visit documents the federal-capacity work in the federal EHR. The cannabis evaluation documents the evaluation in the cannabis evaluation practice’s separate record. When cross-references are clinically necessary, they reference the existence and nature of the other care, not the substantive content of that other care.
A specific example: a federal-capacity note might mention that the patient is being seen by the same provider in a separate cannabis evaluation practice and that the cannabis use is being managed in that separate context. The federal-capacity note does not include the cannabis recommendation itself, the dosing the patient is using, or the clinical rationale developed in the cannabis evaluation. Those live in the cannabis evaluation record.
The boundary the patient should always feel
The strongest signal that the model is working is that the patient experiences the two practices as two practices. They schedule differently. They check in differently. They sign different consent forms. The provider may be the same person, but the patient never has to wonder which visit they’re in. That clarity protects the patient (their care stays organized), protects the practice (the records stay defensible), and protects the provider (the legal separation stays operationally real).
Patients who experience the model as well-run frequently describe it as the most thoughtful clinical relationship they have had with a provider in a long time. The structure that the legal framework requires turns out, in practice, to produce the kind of careful, integrated care that veterans have been hoping for and rarely getting.